Literature DB >> 30785128

At a high dose even partially degraded beta-glucan with decreased solubility significantly reduced the glycaemic response to bread.

Anne Rieder1, Svein H Knutsen, Aida Sainz Fernandez, Simon Ballance.   

Abstract

Cereal beta-glucan can reduce post-prandial glycaemic responses, which makes it an interesting ingredient to improve the health impact of bread, a staple food with a high glycaemic index (GI). Here we compare the ability of different wheat-based breads prepared with oat bran concentrate and barley flour and a Norwegian type of soft wrap (lompe) for their ability to reduce glycaemic responses in healthy adults. Both breads with the highest beta-glucan content (3.8 g per serving) significantly reduced peak blood glucose rise (PBGR), incremental area under the blood glucose curve (iAUC) and GI compared to wheat control regardless of beta-glucan Mw and solubility. At a medium dose of 1.7 g per serving breads with beta-glucan of high MW and solubility significantly lowered iAUC, but not GI or PBGR compared to white bread. In contrast to previous studies, no significant correlation between viscosity after in vitro digestion and any of the glycaemia variables was found. However, the amount of soluble beta-glucan per serving was inversely correlated with GI. Lompe had a similar medium GI (63) than the high dose beta-glucan breads (56 and 64). However, while "lompe" had significantly lower amounts of rapidly digestible starch, no differences in in vitro starch digestion were found between the different breads. Instead, increased local viscosity at the intestinal border (e.g. soluble beta-glucan interacting with the mucus layer), dilution of nutrients (higher water content and serving size) and/or reduced gastric emptying are proposed as potential explanations for the lower glycaemic responses to high dose beta-glucan breads.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30785128     DOI: 10.1039/c8fo02098a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

Review 1.  The importance of molecular weight in determining the minimum dose of oat β-glucan required to reduce the glycaemic response in healthy subjects without diabetes: a systematic review and meta-regression analysis.

Authors:  Jarvis C Noronha; Andreea Zurbau; Thomas M S Wolever
Journal:  Eur J Clin Nutr       Date:  2022-06-29       Impact factor: 4.016

2.  A Three-Day Intervention With Granola Containing Cereal Beta-Glucan Improves Glycemic Response and Changes the Gut Microbiota in Healthy Individuals: A Crossover Study.

Authors:  Vibeke H Telle-Hansen; Line Gaundal; Benedicte Høgvard; Stine M Ulven; Kirsten B Holven; Marte G Byfuglien; Ingrid Måge; Svein Halvor Knutsen; Simon Ballance; Anne Rieder; Ida Rud; Mari C W Myhrstad
Journal:  Front Nutr       Date:  2022-04-28

Review 3.  Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations.

Authors:  Barry W Neun; Edward Cedrone; Timothy M Potter; Rachael M Crist; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

4.  Sixteen-week multicentre randomised controlled trial to study the effect of the consumption of an oat beta-glucan-enriched bread versus a whole-grain wheat bread on glycaemic control among persons with pre-diabetes: a study protocol of the CarbHealth study.

Authors:  Therese Hjorth; Alena Schadow; Ingrid Revheim; Ulrike Spielau; Lise M Thomassen; Klara Meyer; Katja Piotrowski; Hanne Rosendahl-Riise; Anne Rieder; Paula Varela; Vegard Lysne; Simon Ballance; Antje Koerner; Rikard Landberg; Anette Buyken; Jutta Dierkes
Journal:  BMJ Open       Date:  2022-08-23       Impact factor: 3.006

Review 5.  The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis.

Authors:  Andreea Zurbau; Jarvis C Noronha; Tauseef A Khan; John L Sievenpiper; Thomas M S Wolever
Journal:  Eur J Clin Nutr       Date:  2021-02-19       Impact factor: 4.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.